Vimian Group AB (publ) (STO:VIMIAN)
Sweden
· Delayed Price · Currency is SEK 42.60
+0.86 (2.06%)
May 28, 2025, 12:59 PM CET
Vimian Group AB Revenue
Vimian Group AB had revenue of 107.50M EUR in the quarter ending March 31, 2025, with 17.74% growth. This brings the company's revenue in the last twelve months to 391.00M, up 16.75% year-over-year. In the year 2024, Vimian Group AB had annual revenue of 374.80M with 12.99% growth.
Revenue (ttm)
391.00M EUR
Revenue Growth
+16.75%
P/S Ratio
5.15
Revenue / Employee
325.83K EUR
Employees
1,200
Market Cap
21.87B SEK
Revenue Chart
* This company reports financials in EUR.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.24B |
| Sectra AB | 3.30B |
| Getinge AB | 35.57B |
| Asker Healthcare Group AB | 15.57B |
| Medicover AB | 23.56B |
| Camurus AB | 2.04B |
| AddLife AB | 10.42B |
| Vitrolife AB | 3.61B |